Dexcom G7
Commercial- Indications
- Diabetes, Type 1 diabetes, Type 2 diabetes
Company intelligence / Profile preview
Dexcom
San Diego, California, United Statesdexcom.com ↗
- Ownership
- Public · DXCM
- Employees
- ~8000
- Development stage
- Commercial
01
Overview
Dexcom’s CGM systems are FDA-approved and widely used globally for real-time diabetes management. The latest product, Dexcom G7, offers industry-leading accuracy with a MARD of ~8.2%, customizable alerts for hypo/hyperglycemia, and seamless integration with smartphones and insulin pumps. Clinical studies have demonstrated improved glycemic control in both type 1 and type 2 diabetes patients using CGMs compared to traditional fingerstick methods.
- Therapeutic areas
- Endocrinology
- Modalities
- DeviceBiosensor technology (Glucose biosensing)
- Industry
- Physiological Monitoring
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Tandem Diabetes Care (insulin pump integration)Past partnerships with Insulet Corporation & Animas Corporation for device integration
04
Financials
- Market cap
- $31.7B
- Total revenue
- $1.3B
- Enterprise value
- $31.1B
Beyond the preview
Go deeper on Dexcom.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dexcom.